BRISTOL-MYERS SQUIBB PHARMA EEIG
ItalyAll drugs from this manufacturer
-
It is used for the treatment of adults with multiple myeloma, a bone marrow cancer, in cases where previous treatments have not worked or the cancer has recurred.
Dosage form: solution for infusion
Active substance Dosage idecabtagene vicleucel - ATC: L01XL07
-
It is used to treat certain types of cancer: breast cancer (metastatic form), pancreatic cancer (in combination with gemcitabine), and non-small cell lung cancer (in combination with carboplatin).
Dosage form: powder for preparation of injectable suspension
Active substance Dosage paclitaxel - ATC: L01CD01
-
AUGTYRO is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) caused by an alteration in the ROS1 gene. It is also indicated for adults and children aged 12 years and older with solid tumors in various parts of the body caused by an alteration in the NTRK gene.
Dosage form: capsules, hard gelatin
Active substance Dosage repotrectinib - ATC: L01EX28
-
It is an antiviral medicinal product used in adults and children and adolescents (from 2 to 18 years old) to treat chronic hepatitis B virus infection. The drug helps to reduce the amount of virus in the body and to improve liver condition.
Dosage form: tablets, film-coated
Active substance Dosage entecvir - ATC: J05AF10
-
Breyanzi is used for the treatment of adults with certain types of blood cancer (lymphoma) that affect the lymphatic tissues, including diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
Dosage form: solution for infusion
Active substance Dosage lisocabtagene maraleucel - ATC: L01
-
CAMZYOS is used to treat adults with obstructive hypertrophic cardiomyopathy (oHCM), a heart disease in which the walls of the left ventricle thicken, obstructing blood flow.
Dosage form: capsules, hard gelatin
Active substance Dosage mavacamten - ATC: C01EB24
-
Empliciti is used for the treatment of multiple myeloma (a type of bone marrow cancer) in adults, particularly when the cancer has not responded to or has recurred after other treatments.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage elotuzumab - ATC: L01FX08
-
It is used in adults and adolescents (from 12 years of age and weighing at least 35 kg) with HIV to help control the infection, in combination with other anti-HIV medicines.
Dosage form: tablets, film-coated
Active substance Dosage atazanavir (td) - ATC: J05AR15
-
Imnovid is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.
Dosage form: capsules, hard gelatin
Active substance Dosage pomalidomide - ATC: L04AX06
-
It is used to treat adults with an enlarged spleen or with symptoms related to myelofibrosis, a rare form of blood cancer.
Dosage form: capsules, hard gelatin
Active substance Dosage fedratinib - ATC: L01EJ02
-
It is used for the treatment of adults with an advanced or widespread type of lung cancer, called non-small cell lung cancer (NSCLC), when previous treatments have not been effective and the cancer cells have a specific mutation (KRAS G12C).
Dosage form: tablets, film-coated
Active substance Dosage adagrasib - ATC: L01XX77
-
It is used in adults to prevent the immune system from attacking the transplanted kidney, reducing the risk of rejection. It is administered together with other immunosuppressant drugs.
Dosage form: solution for infusion, powder and solvent for preparation
Active substance Dosage belatacept - ATC: L04AA28
-
Onureg is used in adults to treat acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, with the aim of controlling the disease.
Dosage form: tablets, film-coated
Active substance Dosage azacitidine - ATC: L01BC07
-
It is a medicine used for the treatment of several types of cancer, including advanced melanoma, lung cancer (non-small cell), renal cell carcinoma, classical Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, esophageal cancer, and hepatocellular carcinoma.
Dosage form: solution for infusion, concentrate
Active substance Dosage nivolumab - ATC: L01FF01
-
Opdualag is a medicine used for the treatment of advanced melanoma, a type of skin cancer that can spread to other parts of the body. It is indicated for adults and adolescents aged 12 years and older.
Dosage form: solution for infusion, concentrate
Active substance Dosage nivolumab - relatlimab - ATC: L01FY02
-
ORENCIA is used to treat rheumatoid arthritis and psoriatic arthritis in adults, and polyarticular juvenile idiopathic arthritis in children and adolescents (from 2 or 6 years of age depending on the formulation). The drug works by reducing the immune system's attack on normal tissues.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage abatacept - ATC: L04AA24
-
It is used to treat anemia in adults with myelodysplastic syndromes (MDS) or beta-thalassemia. The drug helps the body produce more red blood cells, improving hemoglobin levels and, in patients with MDS, can reduce the need for blood transfusions.
Dosage form: powder for solution for injection
Active substance Dosage luspatercept - ATC: B03XA06
-
This medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard gelatin
Active substance Dosage lenalidomide - ATC: L04AX04
-
It is an antiviral medicinal product used to control human immunodeficiency virus (HIV) infection. It works by reducing the amount of virus in the body and helping to strengthen the immune system.
Dosage form: capsules, hard gelatin
Active substance Dosage atazanavir sulfate - ATC: J05AE08
-
It is used for the treatment of adults with moderate to severe plaque psoriasis, an inflammatory skin condition that can cause red, scaly, itchy, and painful patches.
Dosage form: tablets, film-coated
Active substance Dosage deucravacitinib - ATC: L04AF07
-
It is used for the treatment of chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome-positive (Ph+) in adults, adolescents, and children at least 1 year of age. It is also used for CML in lymph blast crisis in adults who have not responded to other therapies.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib - ATC: L01EA02
-
It is used in combination with melphalan and prednisone for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.
Dosage form: capsules, hard gelatin
Active substance Dosage thalidomide - ATC: L04AX02
-
It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Dosage form: powder for preparation of injectable suspension
Active substance Dosage azacitidine - ATC: L01BC07
-
It is used for the treatment of advanced melanoma in adults and adolescents aged 12 years and older. In combination with other drugs (nivolumab and/or chemotherapy), it can also be used to treat kidney cancer, malignant pleural mesothelioma, colorectal cancer, esophageal cancer, lung cancer, and liver cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage ipilimumab - ATC: L01FX04
-
Zeposia is used for the treatment of adults with active relapsing-remitting multiple sclerosis and for the treatment of adults with active moderate-to-severe ulcerative colitis.
Dosage form: capsules, hard gelatin
Active substance Dosage ozanimod hydrochloride - ozanimod hydrochloride - ATC: L04AE02